trans-1,4-Dibromo-2-butene CAS 821-06-7 Puritas ≥99.0% (GC) Factory High Quality
Manufacturer cum High Quality and Aliquam Price
Commercial Supple Aliskiren intermedia:
Aliskiren CAS: 173334-57-1
Aliskiren Hemifumarate CAS: 173334-58-2
(S)-4-Benzyl-2-Oxazolidinone CAS: 90719-32-7
(R) -4-Benzyl-2-Oxazolidinone CAS: 102029-44-7
trans-1,4-Dibromo-2-Butene CAS: 821-06-7
Isovaleryl Chloride CAS: 108-12-3
D-Phenylalanine CAS: 673-06-3
D-Phenylalaninol CAS: 5267-64-1
| Nomen chemicum | trans-1,4-Dibromo-2-Butene |
| Synonyma | (E) -1,4-Dibromobut-2-ene;(2E)-1,4-Dibromo-2-butene |
| CAS Number | 821-06-7 |
| CATTUS Number | RF-PI149 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C4H6Br2 |
| M. Pondus | 213.9 |
| Solubilitas in Methanol | Prope diaphanum |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | White ad Brown solidum |
| Puritas / Analysis Methodus | ≥99.0% (GC) |
| Cis-Content | ≤0.20% |
| Liquescens punctum | 50.0℃~54.0℃ |
| Tetrabromobutane (TBB) | ≤0.50% |
| Humor (KF) | ≤0.20% |
| Test Standard | Enterprise Standard |
| Consuetudinem | Aliskiren (CAS 173334-57-1), Aliskiren Hemifumarate (CAS 173334-58-2). |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.
Shanghai Ruifu Chemical Co., Ltd. est primarium fabricae et supplementi trans-1,4-Dibromo-2-Butene (CAS: 821-06-7) magna qualitate, late in synthesi organica, synthesi intermedia et pharmaceutica activa medicamentis pharmaceutical (API) synthesis.
trans-1,4-Dibromo-2-Butene (CAS: 821-06-7) clavis media est in synthesi Aliskiren (CAS: 173334-57-1), API.Aliskiren est medicamentum primum in genere antihypertensivum, quod agit per directum renin inhibitionem.Indicatur est administrationis oralis vel monotherapiae vel coniunctionis cum aliis agentibus antihypertensivis.Inhibitio renini ab aliskiren in reductis ordinibus angiotensin I, angiotensin II, et aldosterone, quae omnia ad effectum antihypertensivum conferunt.
